HF
ACON icon

HRT Financial’s Aclarion ACON Stock Holding History

HRT Financial’s Portfolio ACON Stock Details ACON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5
Closed -$6K – 2449
2024
Q4 		$6K Buy
+5
New +$7.62K ﹤0.01% 2313
2024
Q2 		– Sell
-3
Closed -$9K – 2134
2024
Q1 		$9K Buy
+3
New +$44.2K ﹤0.01% 2067
2023
Q4 		– Hold
0
– – – 2127
2023
Q3 		– Hold
0
– -$34K – 2323
2023
Q2 		– Hold
0
– – – 2051

Other funds holding ACON

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

HRT Financial's ACON Position: Q1 2025 in Review

HRT Financial sold out of Aclarion (ACON) in Q1 2025, closing a stake of 5 shares — an estimated $6K sold.

HRT Financial first reported a position in ACON in Q1 2024 and held it in 2 quarters. The position peaked at $9K in Q1 2024. 6 funds tracked by Wall St. Rank hold ACON as of Q1 2025.

  • HRT Financial reported no remaining Aclarion position as of Q1 2025 after selling out during the quarter.
  • HRT Financial sold 5 Aclarion shares in Q1 2025, an estimated $6K.
  • HRT Financial first reported a position in Aclarion in Q1 2024 and held it in 2 quarters.
  • HRT Financial's Aclarion position peaked at $9K in Q1 2024.
  • 6 funds tracked by Wall St. Rank held Aclarion as of Q1 2025.

Based on HRT Financial's 13F filing for Q1 2025, filed 15 May 2025.